Seth P. Lerner, MD (IMAGE)

SWOG Cancer Research Network

Seth P. Lerner, MD

Caption

Seth P. Lerner, MD, led work that found considering RNA-based molecular subtypes modestly improved predictions for pathologic downstaging in muscle-invasive bladder cancer. The results point to the possibility of future clinical trials in this disease that test neoadjuvant therapy that is targeted to the tumor’s molecular subtype.

Credit

SWOG/Baylor College of Medicine

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.